Mercury Biomed is a medical device company.
Mercury approaches temperature management from a truly optimal perspective. Current methods to maintain normal body temperature and medically induce hypothermia do not take into account the human body’s inherent system of temperature control. The Mercury approach works symbiotically with the body’s thermoregulatory system, and the result is a set of devices, methods, and approaches made possible by a strong working knowledge of this complex human physiological system.Mercury is the culmination of 45 years of bioheat transfer research and a deep, unparalleled understanding of human thermoregulation processes coupled with 30 years of medical device startup management experience. Mercury’s scientific minds are at the leading edge of scientific understanding and, paired with its technical and business team, Mercury is arguably the most capable team in the world to advance the science and application of cooling or warming the body core.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 19, 2018 | Grant | $1.50M | 1 | National Institutes of Health | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Institutes of Health | Yes | Grant |